NDC 0024-5915

Dupixent

Dupilumab

Dupixent is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Dupilumab.

• Product ID: 0024-5915_0495c7d4-a900-4b9a-8e7a-8828382c4e7d
• NDC: 0024-5915
• Product Type: Human Prescription Drug
• Proprietary Name: Dupixent
• Generic Name: Dupilumab
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-06-19
• Marketing Category: BLA / BLA
• Application Number: BLA761055
• Labeler Name: sanofi-aventis U.S. LLC
• Substance Name: DUPILUMAB
• Active Ingredient Strength: 300 mg/2mL
• Pharm Classes: Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0024-5915-02

2 SYRINGE, GLASS in 1 CARTON (0024-5915-02) > 2 mL in 1 SYRINGE, GLASS (0024-5915-00)

• Marketing Start Date: 2020-06-19
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Dupixent" or generic name "Dupilumab"

NDC	Brand Name	Generic Name
0024-5911	Dupixent	Dupilumab
0024-5914	Dupixent	Dupilumab
0024-5915	Dupixent	Dupilumab
0024-5916	Dupixent	Dupilumab
0024-5918	Dupixent	Dupixent